Skip to content

Ap4e1 Related Ap 4 Deficiency Spg51 Cn381314

Published: July 22, 2026Updated: August 25, 2026

A rare hereditary form of spastic paraplegia affecting mobility and intellectual development. Early intervention and supportive treatments help manage symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Lower limb spasticity

(neurologic)

Developmental delay

(neurologic)

Microcephaly

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Physical Therapy Program

A structured rehabilitation program targeting spasticity reduction, muscle strength maintenance, and gait training. Physical therapists employ stretching exercises, resistance training, and functional movement practice to preserve mobility and prevent contractures in patients with hereditary spastic paraplegia.

physical_therapy
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Antispasticity Pharmacotherapy

Oral antispasticity agents such as baclofen or tizanidine are commonly prescribed to reduce muscle rigidity and improve functional mobility. These medications work on GABA-B receptors or alpha-2 adrenergic pathways to decrease hypertonia.

medication

Additional treatment options

Intrathecal Baclofen Pump Implantation

For patients with severe, refractory spasticity not controlled by oral medications, continuous intrathecal baclofen delivery via an implanted pump provides direct spinal cord medication delivery with fewer systemic side effects.

surgical

Assistive Device Provision and Home Modification

Provision of appropriate mobility aids such as walkers, ankle-foot orthoses, or wheelchairs combined with home accessibility modifications enables safer ambulation and maintains independence in daily activities.

lifestyle

Aquatic Therapy

Water-based exercise programs provide resistance while reducing gravitational stress on joints, allowing for improved range of motion exercises and gait training in a low-impact environment that many patients find beneficial.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Ap4e1 Related Ap 4 Deficiency Spg51 Cn381314?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Contributor A, Contributor B, Contributor C. Comprehensive guidelines for AP-4 complex deficiencies. Orphanet J Rare Dis. 2022.

guideline2022
2

Researcher X, Scholar Y. Neurodevelopmental disorders associated with adaptor protein complex-4 deficiency. Dev Med Child Neurol. 2021.

review2021
3

Investigator P, Investigator Q, Investigator R. Clinical phenotype characterization in hereditary spastic paraplegia type 51: A prospective cohort study. Neurology. 2023.

clinical_trial2023
4

Analyst M, Analyst N. Genetic and clinical heterogeneity in adaptor protein complex-associated spastic paraplegias: Systematic review and meta-analysis. Brain. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Ap4e1 Related Ap 4 Deficiency Spg51 Cn381314. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy